(1)
Justification for the Composition and Method of Active Pharmaceutical Ingredients Administration at the Development of Suppositories for the Treatment of Benign Prostate Gland Diseases. AJP 2017, 11 (02). https://doi.org/10.22377/ajp.v11i02.1156.